Figure 7. The Kaplan-Meier curve is established according to the amplification potency of BRCA1 Exon 1 or BRCA1 Exon 2 in samples DNA extract. A: represents the Kaplan-Meier curve according to Exon 1 amplification; the median survival time is lower than 20 months for patients with deletion on BRCA1 Exon 1. The difference is statistically significant between patients with Exon1 amplification (blue curve) and patient without exon 1 represented by the red curve (p = 0.0198). B: represents the Kaplan-Meier curve according to Exon 2 amplification; the median survival time is lower than 20 months for patients with deletion on BRCA1 Exon 2. The difference is statistically significant between patients with Exon 2 amplification (blue curve) and patient without exon 2 represented by the red curve (p = 0.0043) : BRCA1 Protein Deficiency in Breast Cancer Microbiopsy Lysate Delineates Patient Survival Time : Science and Education Publishing

Figure 7. The Kaplan-Meier curve is established according to the amplification potency of BRCA1 Exon 1 or BRCA1 Exon 2 in samples DNA extract. A: represents the Kaplan-Meier curve according to Exon 1 amplification; the median survival time is lower than 20 months for patients with deletion on BRCA1 Exon 1. The difference is statistically significant between patients with Exon1 amplification (blue curve) and patient without exon 1 represented by the red curve (p = 0.0198). B: represents the Kaplan-Meier curve according to Exon 2 amplification; the median survival time is lower than 20 months for patients with deletion on BRCA1 Exon 2. The difference is statistically significant between patients with Exon 2 amplification (blue curve) and patient without exon 2 represented by the red curve (p = 0.0043)

Journal of Cancer Research and Treatment. 2021, 9(1), 1-11 doi:10.12691/jcrt-9-1-1